COVID-19 Impact on Global Colorectal Cancer Drugs Market Insights, Forecast to 2026
Colorectal Cancer Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Colorectal Cancer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Colorectal Cancer Drugs market is segmented into
The Colorectal Cancer Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Colorectal Cancer Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Colorectal Cancer Drugs Market Share Analysis
Colorectal Cancer Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Colorectal Cancer Drugs business, the date to enter into the Colorectal Cancer Drugs market, Colorectal Cancer Drugs product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Colorectal Cancer Drugs market is segmented into
- Vascular Endothelial Growth Factor (VEGF) Inhibitors
- Epidermal Growth Factor Receptor (EGFR) Inhibitors
- Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
- BRAF or MEK Inhibitors
- Tyrosine Kinase (TKI) Inhibitors
- Immunomodulators
- Radiotherapy
- Chemotherapy
The Colorectal Cancer Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Colorectal Cancer Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Colorectal Cancer Drugs Market Share Analysis
Colorectal Cancer Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Colorectal Cancer Drugs business, the date to enter into the Colorectal Cancer Drugs market, Colorectal Cancer Drugs product introduction, recent developments, etc.
The major vendors covered:
- AB Science
- Amgen
- Array BioPharma
- Bayer
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Elli Lilly
- Roch
- Hutchison MediPharma
- Merck & Co., Inc.
- Mologen
- Regeneron
- Sanofi
- Sumitomo Dainippon
- Taiho Pharmaceutical
- Vaccinogen
1 STUDY COVERAGE
1.1 Colorectal Cancer Drugs Product Introduction
1.2 Market Segments
1.3 Key Colorectal Cancer Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Colorectal Cancer Drugs Market Size Growth Rate by Type
1.4.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors
1.4.3 Epidermal Growth Factor Receptor (EGFR) Inhibitors
1.4.4 Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
1.4.5 BRAF or MEK Inhibitors
1.4.6 Tyrosine Kinase (TKI) Inhibitors
1.4.7 Immunomodulators
1.5 Market by Application
1.5.1 Global Colorectal Cancer Drugs Market Size Growth Rate by Application
1.5.2 Radiotherapy
1.5.3 Chemotherapy
1.6 Coronavirus Disease 2019 (Covid-19): Colorectal Cancer Drugs Industry Impact
1.6.1 How the Covid-19 is Affecting the Colorectal Cancer Drugs Industry
1.6.1.1 Colorectal Cancer Drugs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Colorectal Cancer Drugs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Colorectal Cancer Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Colorectal Cancer Drugs Market Size Estimates and Forecasts
2.1.1 Global Colorectal Cancer Drugs Revenue 2015-2026
2.1.2 Global Colorectal Cancer Drugs Sales 2015-2026
2.2 Colorectal Cancer Drugs Market Size by Region: 2020 Versus 2026
2.2.1 Global Colorectal Cancer Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Colorectal Cancer Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL COLORECTAL CANCER DRUGS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Colorectal Cancer Drugs Sales by Manufacturers
3.1.1 Colorectal Cancer Drugs Sales by Manufacturers (2015-2020)
3.1.2 Colorectal Cancer Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Colorectal Cancer Drugs Revenue by Manufacturers
3.2.1 Colorectal Cancer Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Colorectal Cancer Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Colorectal Cancer Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Colorectal Cancer Drugs Revenue in 2019
3.2.5 Global Colorectal Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Colorectal Cancer Drugs Price by Manufacturers
3.4 Colorectal Cancer Drugs Manufacturing Base Distribution, Product Types
3.4.1 Colorectal Cancer Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Colorectal Cancer Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Colorectal Cancer Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Colorectal Cancer Drugs Market Size by Type (2015-2020)
4.1.1 Global Colorectal Cancer Drugs Sales by Type (2015-2020)
4.1.2 Global Colorectal Cancer Drugs Revenue by Type (2015-2020)
4.1.3 Colorectal Cancer Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Colorectal Cancer Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Colorectal Cancer Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Colorectal Cancer Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Colorectal Cancer Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Colorectal Cancer Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Colorectal Cancer Drugs Market Size by Application (2015-2020)
5.1.1 Global Colorectal Cancer Drugs Sales by Application (2015-2020)
5.1.2 Global Colorectal Cancer Drugs Revenue by Application (2015-2020)
5.1.3 Colorectal Cancer Drugs Price by Application (2015-2020)
5.2 Colorectal Cancer Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Colorectal Cancer Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Colorectal Cancer Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Colorectal Cancer Drugs Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Colorectal Cancer Drugs by Country
6.1.1 North America Colorectal Cancer Drugs Sales by Country
6.1.2 North America Colorectal Cancer Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Colorectal Cancer Drugs Market Facts & Figures by Type
6.3 North America Colorectal Cancer Drugs Market Facts & Figures by Application
7 EUROPE
7.1 Europe Colorectal Cancer Drugs by Country
7.1.1 Europe Colorectal Cancer Drugs Sales by Country
7.1.2 Europe Colorectal Cancer Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Colorectal Cancer Drugs Market Facts & Figures by Type
7.3 Europe Colorectal Cancer Drugs Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Colorectal Cancer Drugs by Region
8.1.1 Asia Pacific Colorectal Cancer Drugs Sales by Region
8.1.2 Asia Pacific Colorectal Cancer Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Colorectal Cancer Drugs Market Facts & Figures by Type
8.3 Asia Pacific Colorectal Cancer Drugs Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Colorectal Cancer Drugs by Country
9.1.1 Latin America Colorectal Cancer Drugs Sales by Country
9.1.2 Latin America Colorectal Cancer Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Colorectal Cancer Drugs Market Facts & Figures by Type
9.3 Central & South America Colorectal Cancer Drugs Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Colorectal Cancer Drugs by Country
10.1.1 Middle East and Africa Colorectal Cancer Drugs Sales by Country
10.1.2 Middle East and Africa Colorectal Cancer Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Colorectal Cancer Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Colorectal Cancer Drugs Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 AB Science
11.1.1 AB Science Corporation Information
11.1.2 AB Science Description, Business Overview and Total Revenue
11.1.3 AB Science Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AB Science Colorectal Cancer Drugs Products Offered
11.1.5 AB Science Recent Development
11.2 Amgen
11.2.1 Amgen Corporation Information
11.2.2 Amgen Description, Business Overview and Total Revenue
11.2.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Amgen Colorectal Cancer Drugs Products Offered
11.2.5 Amgen Recent Development
11.3 Array BioPharma
11.3.1 Array BioPharma Corporation Information
11.3.2 Array BioPharma Description, Business Overview and Total Revenue
11.3.3 Array BioPharma Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Array BioPharma Colorectal Cancer Drugs Products Offered
11.3.5 Array BioPharma Recent Development
11.4 Bayer
11.4.1 Bayer Corporation Information
11.4.2 Bayer Description, Business Overview and Total Revenue
11.4.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Bayer Colorectal Cancer Drugs Products Offered
11.4.5 Bayer Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Corporation Information
11.5.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
11.5.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Boehringer Ingelheim Colorectal Cancer Drugs Products Offered
11.5.5 Boehringer Ingelheim Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Corporation Information
11.6.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
11.6.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bristol-Myers Squibb Colorectal Cancer Drugs Products Offered
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Elli Lilly
11.7.1 Elli Lilly Corporation Information
11.7.2 Elli Lilly Description, Business Overview and Total Revenue
11.7.3 Elli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Elli Lilly Colorectal Cancer Drugs Products Offered
11.7.5 Elli Lilly Recent Development
11.8 Roch
11.8.1 Roch Corporation Information
11.8.2 Roch Description, Business Overview and Total Revenue
11.8.3 Roch Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Roch Colorectal Cancer Drugs Products Offered
11.8.5 Roch Recent Development
11.9 Hutchison MediPharma
11.9.1 Hutchison MediPharma Corporation Information
11.9.2 Hutchison MediPharma Description, Business Overview and Total Revenue
11.9.3 Hutchison MediPharma Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Hutchison MediPharma Colorectal Cancer Drugs Products Offered
11.9.5 Hutchison MediPharma Recent Development
11.10 Merck & Co., Inc.
11.10.1 Merck & Co., Inc. Corporation Information
11.10.2 Merck & Co., Inc. Description, Business Overview and Total Revenue
11.10.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Merck & Co., Inc. Colorectal Cancer Drugs Products Offered
11.10.5 Merck & Co., Inc. Recent Development
11.1 AB Science
11.1.1 AB Science Corporation Information
11.1.2 AB Science Description, Business Overview and Total Revenue
11.1.3 AB Science Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AB Science Colorectal Cancer Drugs Products Offered
11.1.5 AB Science Recent Development
11.12 Regeneron
11.12.1 Regeneron Corporation Information
11.12.2 Regeneron Description, Business Overview and Total Revenue
11.12.3 Regeneron Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Regeneron Products Offered
11.12.5 Regeneron Recent Development
11.13 Sanofi
11.13.1 Sanofi Corporation Information
11.13.2 Sanofi Description, Business Overview and Total Revenue
11.13.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Sanofi Products Offered
11.13.5 Sanofi Recent Development
11.14 Sumitomo Dainippon
11.14.1 Sumitomo Dainippon Corporation Information
11.14.2 Sumitomo Dainippon Description, Business Overview and Total Revenue
11.14.3 Sumitomo Dainippon Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Sumitomo Dainippon Products Offered
11.14.5 Sumitomo Dainippon Recent Development
11.15 Taiho Pharmaceutical
11.15.1 Taiho Pharmaceutical Corporation Information
11.15.2 Taiho Pharmaceutical Description, Business Overview and Total Revenue
11.15.3 Taiho Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Taiho Pharmaceutical Products Offered
11.15.5 Taiho Pharmaceutical Recent Development
11.16 Vaccinogen
11.16.1 Vaccinogen Corporation Information
11.16.2 Vaccinogen Description, Business Overview and Total Revenue
11.16.3 Vaccinogen Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Vaccinogen Products Offered
11.16.5 Vaccinogen Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Colorectal Cancer Drugs Market Estimates and Projections by Region
12.1.1 Global Colorectal Cancer Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Colorectal Cancer Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Colorectal Cancer Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Colorectal Cancer Drugs Sales Forecast (2021-2026)
12.2.2 North America: Colorectal Cancer Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Colorectal Cancer Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Colorectal Cancer Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Colorectal Cancer Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Colorectal Cancer Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Colorectal Cancer Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Colorectal Cancer Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Colorectal Cancer Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Colorectal Cancer Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Colorectal Cancer Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Colorectal Cancer Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Colorectal Cancer Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Colorectal Cancer Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Colorectal Cancer Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Colorectal Cancer Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Colorectal Cancer Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Colorectal Cancer Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Colorectal Cancer Drugs Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Colorectal Cancer Drugs Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Colorectal Cancer Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Colorectal Cancer Drugs Product Introduction
1.2 Market Segments
1.3 Key Colorectal Cancer Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Colorectal Cancer Drugs Market Size Growth Rate by Type
1.4.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors
1.4.3 Epidermal Growth Factor Receptor (EGFR) Inhibitors
1.4.4 Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
1.4.5 BRAF or MEK Inhibitors
1.4.6 Tyrosine Kinase (TKI) Inhibitors
1.4.7 Immunomodulators
1.5 Market by Application
1.5.1 Global Colorectal Cancer Drugs Market Size Growth Rate by Application
1.5.2 Radiotherapy
1.5.3 Chemotherapy
1.6 Coronavirus Disease 2019 (Covid-19): Colorectal Cancer Drugs Industry Impact
1.6.1 How the Covid-19 is Affecting the Colorectal Cancer Drugs Industry
1.6.1.1 Colorectal Cancer Drugs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Colorectal Cancer Drugs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Colorectal Cancer Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Colorectal Cancer Drugs Market Size Estimates and Forecasts
2.1.1 Global Colorectal Cancer Drugs Revenue 2015-2026
2.1.2 Global Colorectal Cancer Drugs Sales 2015-2026
2.2 Colorectal Cancer Drugs Market Size by Region: 2020 Versus 2026
2.2.1 Global Colorectal Cancer Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Colorectal Cancer Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL COLORECTAL CANCER DRUGS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Colorectal Cancer Drugs Sales by Manufacturers
3.1.1 Colorectal Cancer Drugs Sales by Manufacturers (2015-2020)
3.1.2 Colorectal Cancer Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Colorectal Cancer Drugs Revenue by Manufacturers
3.2.1 Colorectal Cancer Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Colorectal Cancer Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Colorectal Cancer Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Colorectal Cancer Drugs Revenue in 2019
3.2.5 Global Colorectal Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Colorectal Cancer Drugs Price by Manufacturers
3.4 Colorectal Cancer Drugs Manufacturing Base Distribution, Product Types
3.4.1 Colorectal Cancer Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Colorectal Cancer Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Colorectal Cancer Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Colorectal Cancer Drugs Market Size by Type (2015-2020)
4.1.1 Global Colorectal Cancer Drugs Sales by Type (2015-2020)
4.1.2 Global Colorectal Cancer Drugs Revenue by Type (2015-2020)
4.1.3 Colorectal Cancer Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Colorectal Cancer Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Colorectal Cancer Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Colorectal Cancer Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Colorectal Cancer Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Colorectal Cancer Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Colorectal Cancer Drugs Market Size by Application (2015-2020)
5.1.1 Global Colorectal Cancer Drugs Sales by Application (2015-2020)
5.1.2 Global Colorectal Cancer Drugs Revenue by Application (2015-2020)
5.1.3 Colorectal Cancer Drugs Price by Application (2015-2020)
5.2 Colorectal Cancer Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Colorectal Cancer Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Colorectal Cancer Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Colorectal Cancer Drugs Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Colorectal Cancer Drugs by Country
6.1.1 North America Colorectal Cancer Drugs Sales by Country
6.1.2 North America Colorectal Cancer Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Colorectal Cancer Drugs Market Facts & Figures by Type
6.3 North America Colorectal Cancer Drugs Market Facts & Figures by Application
7 EUROPE
7.1 Europe Colorectal Cancer Drugs by Country
7.1.1 Europe Colorectal Cancer Drugs Sales by Country
7.1.2 Europe Colorectal Cancer Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Colorectal Cancer Drugs Market Facts & Figures by Type
7.3 Europe Colorectal Cancer Drugs Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Colorectal Cancer Drugs by Region
8.1.1 Asia Pacific Colorectal Cancer Drugs Sales by Region
8.1.2 Asia Pacific Colorectal Cancer Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Colorectal Cancer Drugs Market Facts & Figures by Type
8.3 Asia Pacific Colorectal Cancer Drugs Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Colorectal Cancer Drugs by Country
9.1.1 Latin America Colorectal Cancer Drugs Sales by Country
9.1.2 Latin America Colorectal Cancer Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Colorectal Cancer Drugs Market Facts & Figures by Type
9.3 Central & South America Colorectal Cancer Drugs Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Colorectal Cancer Drugs by Country
10.1.1 Middle East and Africa Colorectal Cancer Drugs Sales by Country
10.1.2 Middle East and Africa Colorectal Cancer Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Colorectal Cancer Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Colorectal Cancer Drugs Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 AB Science
11.1.1 AB Science Corporation Information
11.1.2 AB Science Description, Business Overview and Total Revenue
11.1.3 AB Science Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AB Science Colorectal Cancer Drugs Products Offered
11.1.5 AB Science Recent Development
11.2 Amgen
11.2.1 Amgen Corporation Information
11.2.2 Amgen Description, Business Overview and Total Revenue
11.2.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Amgen Colorectal Cancer Drugs Products Offered
11.2.5 Amgen Recent Development
11.3 Array BioPharma
11.3.1 Array BioPharma Corporation Information
11.3.2 Array BioPharma Description, Business Overview and Total Revenue
11.3.3 Array BioPharma Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Array BioPharma Colorectal Cancer Drugs Products Offered
11.3.5 Array BioPharma Recent Development
11.4 Bayer
11.4.1 Bayer Corporation Information
11.4.2 Bayer Description, Business Overview and Total Revenue
11.4.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Bayer Colorectal Cancer Drugs Products Offered
11.4.5 Bayer Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Corporation Information
11.5.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
11.5.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Boehringer Ingelheim Colorectal Cancer Drugs Products Offered
11.5.5 Boehringer Ingelheim Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Corporation Information
11.6.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
11.6.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bristol-Myers Squibb Colorectal Cancer Drugs Products Offered
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Elli Lilly
11.7.1 Elli Lilly Corporation Information
11.7.2 Elli Lilly Description, Business Overview and Total Revenue
11.7.3 Elli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Elli Lilly Colorectal Cancer Drugs Products Offered
11.7.5 Elli Lilly Recent Development
11.8 Roch
11.8.1 Roch Corporation Information
11.8.2 Roch Description, Business Overview and Total Revenue
11.8.3 Roch Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Roch Colorectal Cancer Drugs Products Offered
11.8.5 Roch Recent Development
11.9 Hutchison MediPharma
11.9.1 Hutchison MediPharma Corporation Information
11.9.2 Hutchison MediPharma Description, Business Overview and Total Revenue
11.9.3 Hutchison MediPharma Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Hutchison MediPharma Colorectal Cancer Drugs Products Offered
11.9.5 Hutchison MediPharma Recent Development
11.10 Merck & Co., Inc.
11.10.1 Merck & Co., Inc. Corporation Information
11.10.2 Merck & Co., Inc. Description, Business Overview and Total Revenue
11.10.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Merck & Co., Inc. Colorectal Cancer Drugs Products Offered
11.10.5 Merck & Co., Inc. Recent Development
11.1 AB Science
11.1.1 AB Science Corporation Information
11.1.2 AB Science Description, Business Overview and Total Revenue
11.1.3 AB Science Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AB Science Colorectal Cancer Drugs Products Offered
11.1.5 AB Science Recent Development
11.12 Regeneron
11.12.1 Regeneron Corporation Information
11.12.2 Regeneron Description, Business Overview and Total Revenue
11.12.3 Regeneron Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Regeneron Products Offered
11.12.5 Regeneron Recent Development
11.13 Sanofi
11.13.1 Sanofi Corporation Information
11.13.2 Sanofi Description, Business Overview and Total Revenue
11.13.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Sanofi Products Offered
11.13.5 Sanofi Recent Development
11.14 Sumitomo Dainippon
11.14.1 Sumitomo Dainippon Corporation Information
11.14.2 Sumitomo Dainippon Description, Business Overview and Total Revenue
11.14.3 Sumitomo Dainippon Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Sumitomo Dainippon Products Offered
11.14.5 Sumitomo Dainippon Recent Development
11.15 Taiho Pharmaceutical
11.15.1 Taiho Pharmaceutical Corporation Information
11.15.2 Taiho Pharmaceutical Description, Business Overview and Total Revenue
11.15.3 Taiho Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Taiho Pharmaceutical Products Offered
11.15.5 Taiho Pharmaceutical Recent Development
11.16 Vaccinogen
11.16.1 Vaccinogen Corporation Information
11.16.2 Vaccinogen Description, Business Overview and Total Revenue
11.16.3 Vaccinogen Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Vaccinogen Products Offered
11.16.5 Vaccinogen Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Colorectal Cancer Drugs Market Estimates and Projections by Region
12.1.1 Global Colorectal Cancer Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Colorectal Cancer Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Colorectal Cancer Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Colorectal Cancer Drugs Sales Forecast (2021-2026)
12.2.2 North America: Colorectal Cancer Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Colorectal Cancer Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Colorectal Cancer Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Colorectal Cancer Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Colorectal Cancer Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Colorectal Cancer Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Colorectal Cancer Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Colorectal Cancer Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Colorectal Cancer Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Colorectal Cancer Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Colorectal Cancer Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Colorectal Cancer Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Colorectal Cancer Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Colorectal Cancer Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Colorectal Cancer Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Colorectal Cancer Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Colorectal Cancer Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Colorectal Cancer Drugs Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Colorectal Cancer Drugs Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Colorectal Cancer Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Colorectal Cancer Drugs Market Segments
Table 2. Ranking of Global Top Colorectal Cancer Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Colorectal Cancer Drugs Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Vascular Endothelial Growth Factor (VEGF) Inhibitors
Table 5. Major Manufacturers of Epidermal Growth Factor Receptor (EGFR) Inhibitors
Table 6. Major Manufacturers of Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
Table 7. Major Manufacturers of BRAF or MEK Inhibitors
Table 8. Major Manufacturers of Tyrosine Kinase (TKI) Inhibitors
Table 9. Major Manufacturers of Immunomodulators
Table 10. COVID-19 Impact Global Market: (Four Colorectal Cancer Drugs Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Colorectal Cancer Drugs Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Colorectal Cancer Drugs Players to Combat Covid-19 Impact
Table 15. Global Colorectal Cancer Drugs Market Size Growth Rate by Application 2020-2026 (MT)
Table 16. Global Colorectal Cancer Drugs Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 17. Global Colorectal Cancer Drugs Sales by Regions 2015-2020 (MT)
Table 18. Global Colorectal Cancer Drugs Sales Market Share by Regions (2015-2020)
Table 19. Global Colorectal Cancer Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 20. Global Colorectal Cancer Drugs Sales by Manufacturers (2015-2020) (MT)
Table 21. Global Colorectal Cancer Drugs Sales Share by Manufacturers (2015-2020)
Table 22. Global Colorectal Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 23. Global Colorectal Cancer Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colorectal Cancer Drugs as of 2019)
Table 24. Colorectal Cancer Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 25. Colorectal Cancer Drugs Revenue Share by Manufacturers (2015-2020)
Table 26. Key Manufacturers Colorectal Cancer Drugs Price (2015-2020) (USD/Kg)
Table 27. Colorectal Cancer Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 28. Manufacturers Colorectal Cancer Drugs Product Type
Table 29. Date of International Manufacturers Enter into Colorectal Cancer Drugs Market
Table 30. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 31. Global Colorectal Cancer Drugs Sales by Type (2015-2020) (MT)
Table 32. Global Colorectal Cancer Drugs Sales Share by Type (2015-2020)
Table 33. Global Colorectal Cancer Drugs Revenue by Type (2015-2020) (US$ Million)
Table 34. Global Colorectal Cancer Drugs Revenue Share by Type (2015-2020)
Table 35. Colorectal Cancer Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 36. Global Colorectal Cancer Drugs Sales by Application (2015-2020) (MT)
Table 37. Global Colorectal Cancer Drugs Sales Share by Application (2015-2020)
Table 38. North America Colorectal Cancer Drugs Sales by Country (2015-2020) (MT)
Table 39. North America Colorectal Cancer Drugs Sales Market Share by Country (2015-2020)
Table 40. North America Colorectal Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 41. North America Colorectal Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 42. North America Colorectal Cancer Drugs Sales by Type (2015-2020) (MT)
Table 43. North America Colorectal Cancer Drugs Sales Market Share by Type (2015-2020)
Table 44. North America Colorectal Cancer Drugs Sales by Application (2015-2020) (MT)
Table 45. North America Colorectal Cancer Drugs Sales Market Share by Application (2015-2020)
Table 46. Europe Colorectal Cancer Drugs Sales by Country (2015-2020) (MT)
Table 47. Europe Colorectal Cancer Drugs Sales Market Share by Country (2015-2020)
Table 48. Europe Colorectal Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 49. Europe Colorectal Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 50. Europe Colorectal Cancer Drugs Sales by Type (2015-2020) (MT)
Table 51. Europe Colorectal Cancer Drugs Sales Market Share by Type (2015-2020)
Table 52. Europe Colorectal Cancer Drugs Sales by Application (2015-2020) (MT)
Table 53. Europe Colorectal Cancer Drugs Sales Market Share by Application (2015-2020)
Table 54. Asia Pacific Colorectal Cancer Drugs Sales by Region (2015-2020) (MT)
Table 55. Asia Pacific Colorectal Cancer Drugs Sales Market Share by Region (2015-2020)
Table 56. Asia Pacific Colorectal Cancer Drugs Revenue by Region (2015-2020) (US$ Million)
Table 57. Asia Pacific Colorectal Cancer Drugs Revenue Market Share by Region (2015-2020)
Table 58. Asia Pacific Colorectal Cancer Drugs Sales by Type (2015-2020) (MT)
Table 59. Asia Pacific Colorectal Cancer Drugs Sales Market Share by Type (2015-2020)
Table 60. Asia Pacific Colorectal Cancer Drugs Sales by Application (2015-2020) (MT)
Table 61. Asia Pacific Colorectal Cancer Drugs Sales Market Share by Application (2015-2020)
Table 62. Latin America Colorectal Cancer Drugs Sales by Country (2015-2020) (MT)
Table 63. Latin America Colorectal Cancer Drugs Sales Market Share by Country (2015-2020)
Table 64. Latin Americaa Colorectal Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 65. Latin America Colorectal Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 66. Latin America Colorectal Cancer Drugs Sales by Type (2015-2020) (MT)
Table 67. Latin America Colorectal Cancer Drugs Sales Market Share by Type (2015-2020)
Table 68. Latin America Colorectal Cancer Drugs Sales by Application (2015-2020) (MT)
Table 69. Latin America Colorectal Cancer Drugs Sales Market Share by Application (2015-2020)
Table 70. Middle East and Africa Colorectal Cancer Drugs Sales by Country (2015-2020) (MT)
Table 71. Middle East and Africa Colorectal Cancer Drugs Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Colorectal Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Colorectal Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 74. Middle East and Africa Colorectal Cancer Drugs Sales by Type (2015-2020) (MT)
Table 75. Middle East and Africa Colorectal Cancer Drugs Sales Market Share by Type (2015-2020)
Table 76. Middle East and Africa Colorectal Cancer Drugs Sales by Application (2015-2020) (MT)
Table 77. Middle East and Africa Colorectal Cancer Drugs Sales Market Share by Application (2015-2020)
Table 78. AB Science Corporation Information
Table 79. AB Science Description and Major Businesses
Table 80. AB Science Colorectal Cancer Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 81. AB Science Product
Table 82. AB Science Recent Development
Table 83. Amgen Corporation Information
Table 84. Amgen Description and Major Businesses
Table 85. Amgen Colorectal Cancer Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 86. Amgen Product
Table 87. Amgen Recent Development
Table 88. Array BioPharma Corporation Information
Table 89. Array BioPharma Description and Major Businesses
Table 90. Array BioPharma Colorectal Cancer Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 91. Array BioPharma Product
Table 92. Array BioPharma Recent Development
Table 93. Bayer Corporation Information
Table 94. Bayer Description and Major Businesses
Table 95. Bayer Colorectal Cancer Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 96. Bayer Product
Table 97. Bayer Recent Development
Table 98. Boehringer Ingelheim Corporation Information
Table 99. Boehringer Ingelheim Description and Major Businesses
Table 100. Boehringer Ingelheim Colorectal Cancer Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 101. Boehringer Ingelheim Product
Table 102. Boehringer Ingelheim Recent Development
Table 103. Bristol-Myers Squibb Corporation Information
Table 104. Bristol-Myers Squibb Description and Major Businesses
Table 105. Bristol-Myers Squibb Colorectal Cancer Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 106. Bristol-Myers Squibb Product
Table 107. Bristol-Myers Squibb Recent Development
Table 108. Elli Lilly Corporation Information
Table 109. Elli Lilly Description and Major Businesses
Table 110. Elli Lilly Colorectal Cancer Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 111. Elli Lilly Product
Table 112. Elli Lilly Recent Development
Table 113. Roch Corporation Information
Table 114. Roch Description and Major Businesses
Table 115. Roch Colorectal Cancer Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 116. Roch Product
Table 117. Roch Recent Development
Table 118. Hutchison MediPharma Corporation Information
Table 119. Hutchison MediPharma Description and Major Businesses
Table 120. Hutchison MediPharma Colorectal Cancer Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 121. Hutchison MediPharma Product
Table 122. Hutchison MediPharma Recent Development
Table 123. Merck & Co., Inc. Corporation Information
Table 124. Merck & Co., Inc. Description and Major Businesses
Table 125. Merck & Co., Inc. Colorectal Cancer Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 126. Merck & Co., Inc. Product
Table 127. Merck & Co., Inc. Recent Development
Table 128. Mologen Corporation Information
Table 129. Mologen Description and Major Businesses
Table 130. Mologen Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 131. Mologen Product
Table 132. Mologen Recent Development
Table 133. Regeneron Corporation Information
Table 134. Regeneron Description and Major Businesses
Table 135. Regeneron Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 136. Regeneron Product
Table 137. Regeneron Recent Development
Table 138. Sanofi Corporation Information
Table 139. Sanofi Description and Major Businesses
Table 140. Sanofi Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 141. Sanofi Product
Table 142. Sanofi Recent Development
Table 143. Sumitomo Dainippon Corporation Information
Table 144. Sumitomo Dainippon Description and Major Businesses
Table 145. Sumitomo Dainippon Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 146. Sumitomo Dainippon Product
Table 147. Sumitomo Dainippon Recent Development
Table 148. Taiho Pharmaceutical Corporation Information
Table 149. Taiho Pharmaceutical Description and Major Businesses
Table 150. Taiho Pharmaceutical Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 151. Taiho Pharmaceutical Product
Table 152. Taiho Pharmaceutical Recent Development
Table 153. Vaccinogen Corporation Information
Table 154. Vaccinogen Description and Major Businesses
Table 155. Vaccinogen Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 156. Vaccinogen Product
Table 157. Vaccinogen Recent Development
Table 158. Global Colorectal Cancer Drugs Sales Forecast by Regions (2021-2026) (MT)
Table 159. Global Colorectal Cancer Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 160. Global Colorectal Cancer Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 161. Global Colorectal Cancer Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 162. North America: Colorectal Cancer Drugs Sales Forecast by Country (2021-2026) (MT)
Table 163. North America: Colorectal Cancer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 164. Europe: Colorectal Cancer Drugs Sales Forecast by Country (2021-2026) (MT)
Table 165. Europe: Colorectal Cancer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 166. Asia Pacific: Colorectal Cancer Drugs Sales Forecast by Region (2021-2026) (MT)
Table 167. Asia Pacific: Colorectal Cancer Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 168. Latin America: Colorectal Cancer Drugs Sales Forecast by Country (2021-2026) (MT)
Table 169. Latin America: Colorectal Cancer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 170. Middle East and Africa: Colorectal Cancer Drugs Sales Forecast by Country (2021-2026) (MT)
Table 171. Middle East and Africa: Colorectal Cancer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 172. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 173. Key Challenges
Table 174. Market Risks
Table 175. Main Points Interviewed from Key Colorectal Cancer Drugs Players
Table 176. Colorectal Cancer Drugs Customers List
Table 177. Colorectal Cancer Drugs Distributors List
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 1. Colorectal Cancer Drugs Market Segments
Table 2. Ranking of Global Top Colorectal Cancer Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Colorectal Cancer Drugs Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Vascular Endothelial Growth Factor (VEGF) Inhibitors
Table 5. Major Manufacturers of Epidermal Growth Factor Receptor (EGFR) Inhibitors
Table 6. Major Manufacturers of Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
Table 7. Major Manufacturers of BRAF or MEK Inhibitors
Table 8. Major Manufacturers of Tyrosine Kinase (TKI) Inhibitors
Table 9. Major Manufacturers of Immunomodulators
Table 10. COVID-19 Impact Global Market: (Four Colorectal Cancer Drugs Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Colorectal Cancer Drugs Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Colorectal Cancer Drugs Players to Combat Covid-19 Impact
Table 15. Global Colorectal Cancer Drugs Market Size Growth Rate by Application 2020-2026 (MT)
Table 16. Global Colorectal Cancer Drugs Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 17. Global Colorectal Cancer Drugs Sales by Regions 2015-2020 (MT)
Table 18. Global Colorectal Cancer Drugs Sales Market Share by Regions (2015-2020)
Table 19. Global Colorectal Cancer Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 20. Global Colorectal Cancer Drugs Sales by Manufacturers (2015-2020) (MT)
Table 21. Global Colorectal Cancer Drugs Sales Share by Manufacturers (2015-2020)
Table 22. Global Colorectal Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 23. Global Colorectal Cancer Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colorectal Cancer Drugs as of 2019)
Table 24. Colorectal Cancer Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 25. Colorectal Cancer Drugs Revenue Share by Manufacturers (2015-2020)
Table 26. Key Manufacturers Colorectal Cancer Drugs Price (2015-2020) (USD/Kg)
Table 27. Colorectal Cancer Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 28. Manufacturers Colorectal Cancer Drugs Product Type
Table 29. Date of International Manufacturers Enter into Colorectal Cancer Drugs Market
Table 30. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 31. Global Colorectal Cancer Drugs Sales by Type (2015-2020) (MT)
Table 32. Global Colorectal Cancer Drugs Sales Share by Type (2015-2020)
Table 33. Global Colorectal Cancer Drugs Revenue by Type (2015-2020) (US$ Million)
Table 34. Global Colorectal Cancer Drugs Revenue Share by Type (2015-2020)
Table 35. Colorectal Cancer Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 36. Global Colorectal Cancer Drugs Sales by Application (2015-2020) (MT)
Table 37. Global Colorectal Cancer Drugs Sales Share by Application (2015-2020)
Table 38. North America Colorectal Cancer Drugs Sales by Country (2015-2020) (MT)
Table 39. North America Colorectal Cancer Drugs Sales Market Share by Country (2015-2020)
Table 40. North America Colorectal Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 41. North America Colorectal Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 42. North America Colorectal Cancer Drugs Sales by Type (2015-2020) (MT)
Table 43. North America Colorectal Cancer Drugs Sales Market Share by Type (2015-2020)
Table 44. North America Colorectal Cancer Drugs Sales by Application (2015-2020) (MT)
Table 45. North America Colorectal Cancer Drugs Sales Market Share by Application (2015-2020)
Table 46. Europe Colorectal Cancer Drugs Sales by Country (2015-2020) (MT)
Table 47. Europe Colorectal Cancer Drugs Sales Market Share by Country (2015-2020)
Table 48. Europe Colorectal Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 49. Europe Colorectal Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 50. Europe Colorectal Cancer Drugs Sales by Type (2015-2020) (MT)
Table 51. Europe Colorectal Cancer Drugs Sales Market Share by Type (2015-2020)
Table 52. Europe Colorectal Cancer Drugs Sales by Application (2015-2020) (MT)
Table 53. Europe Colorectal Cancer Drugs Sales Market Share by Application (2015-2020)
Table 54. Asia Pacific Colorectal Cancer Drugs Sales by Region (2015-2020) (MT)
Table 55. Asia Pacific Colorectal Cancer Drugs Sales Market Share by Region (2015-2020)
Table 56. Asia Pacific Colorectal Cancer Drugs Revenue by Region (2015-2020) (US$ Million)
Table 57. Asia Pacific Colorectal Cancer Drugs Revenue Market Share by Region (2015-2020)
Table 58. Asia Pacific Colorectal Cancer Drugs Sales by Type (2015-2020) (MT)
Table 59. Asia Pacific Colorectal Cancer Drugs Sales Market Share by Type (2015-2020)
Table 60. Asia Pacific Colorectal Cancer Drugs Sales by Application (2015-2020) (MT)
Table 61. Asia Pacific Colorectal Cancer Drugs Sales Market Share by Application (2015-2020)
Table 62. Latin America Colorectal Cancer Drugs Sales by Country (2015-2020) (MT)
Table 63. Latin America Colorectal Cancer Drugs Sales Market Share by Country (2015-2020)
Table 64. Latin Americaa Colorectal Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 65. Latin America Colorectal Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 66. Latin America Colorectal Cancer Drugs Sales by Type (2015-2020) (MT)
Table 67. Latin America Colorectal Cancer Drugs Sales Market Share by Type (2015-2020)
Table 68. Latin America Colorectal Cancer Drugs Sales by Application (2015-2020) (MT)
Table 69. Latin America Colorectal Cancer Drugs Sales Market Share by Application (2015-2020)
Table 70. Middle East and Africa Colorectal Cancer Drugs Sales by Country (2015-2020) (MT)
Table 71. Middle East and Africa Colorectal Cancer Drugs Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Colorectal Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Colorectal Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 74. Middle East and Africa Colorectal Cancer Drugs Sales by Type (2015-2020) (MT)
Table 75. Middle East and Africa Colorectal Cancer Drugs Sales Market Share by Type (2015-2020)
Table 76. Middle East and Africa Colorectal Cancer Drugs Sales by Application (2015-2020) (MT)
Table 77. Middle East and Africa Colorectal Cancer Drugs Sales Market Share by Application (2015-2020)
Table 78. AB Science Corporation Information
Table 79. AB Science Description and Major Businesses
Table 80. AB Science Colorectal Cancer Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 81. AB Science Product
Table 82. AB Science Recent Development
Table 83. Amgen Corporation Information
Table 84. Amgen Description and Major Businesses
Table 85. Amgen Colorectal Cancer Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 86. Amgen Product
Table 87. Amgen Recent Development
Table 88. Array BioPharma Corporation Information
Table 89. Array BioPharma Description and Major Businesses
Table 90. Array BioPharma Colorectal Cancer Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 91. Array BioPharma Product
Table 92. Array BioPharma Recent Development
Table 93. Bayer Corporation Information
Table 94. Bayer Description and Major Businesses
Table 95. Bayer Colorectal Cancer Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 96. Bayer Product
Table 97. Bayer Recent Development
Table 98. Boehringer Ingelheim Corporation Information
Table 99. Boehringer Ingelheim Description and Major Businesses
Table 100. Boehringer Ingelheim Colorectal Cancer Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 101. Boehringer Ingelheim Product
Table 102. Boehringer Ingelheim Recent Development
Table 103. Bristol-Myers Squibb Corporation Information
Table 104. Bristol-Myers Squibb Description and Major Businesses
Table 105. Bristol-Myers Squibb Colorectal Cancer Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 106. Bristol-Myers Squibb Product
Table 107. Bristol-Myers Squibb Recent Development
Table 108. Elli Lilly Corporation Information
Table 109. Elli Lilly Description and Major Businesses
Table 110. Elli Lilly Colorectal Cancer Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 111. Elli Lilly Product
Table 112. Elli Lilly Recent Development
Table 113. Roch Corporation Information
Table 114. Roch Description and Major Businesses
Table 115. Roch Colorectal Cancer Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 116. Roch Product
Table 117. Roch Recent Development
Table 118. Hutchison MediPharma Corporation Information
Table 119. Hutchison MediPharma Description and Major Businesses
Table 120. Hutchison MediPharma Colorectal Cancer Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 121. Hutchison MediPharma Product
Table 122. Hutchison MediPharma Recent Development
Table 123. Merck & Co., Inc. Corporation Information
Table 124. Merck & Co., Inc. Description and Major Businesses
Table 125. Merck & Co., Inc. Colorectal Cancer Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 126. Merck & Co., Inc. Product
Table 127. Merck & Co., Inc. Recent Development
Table 128. Mologen Corporation Information
Table 129. Mologen Description and Major Businesses
Table 130. Mologen Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 131. Mologen Product
Table 132. Mologen Recent Development
Table 133. Regeneron Corporation Information
Table 134. Regeneron Description and Major Businesses
Table 135. Regeneron Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 136. Regeneron Product
Table 137. Regeneron Recent Development
Table 138. Sanofi Corporation Information
Table 139. Sanofi Description and Major Businesses
Table 140. Sanofi Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 141. Sanofi Product
Table 142. Sanofi Recent Development
Table 143. Sumitomo Dainippon Corporation Information
Table 144. Sumitomo Dainippon Description and Major Businesses
Table 145. Sumitomo Dainippon Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 146. Sumitomo Dainippon Product
Table 147. Sumitomo Dainippon Recent Development
Table 148. Taiho Pharmaceutical Corporation Information
Table 149. Taiho Pharmaceutical Description and Major Businesses
Table 150. Taiho Pharmaceutical Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 151. Taiho Pharmaceutical Product
Table 152. Taiho Pharmaceutical Recent Development
Table 153. Vaccinogen Corporation Information
Table 154. Vaccinogen Description and Major Businesses
Table 155. Vaccinogen Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 156. Vaccinogen Product
Table 157. Vaccinogen Recent Development
Table 158. Global Colorectal Cancer Drugs Sales Forecast by Regions (2021-2026) (MT)
Table 159. Global Colorectal Cancer Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 160. Global Colorectal Cancer Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 161. Global Colorectal Cancer Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 162. North America: Colorectal Cancer Drugs Sales Forecast by Country (2021-2026) (MT)
Table 163. North America: Colorectal Cancer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 164. Europe: Colorectal Cancer Drugs Sales Forecast by Country (2021-2026) (MT)
Table 165. Europe: Colorectal Cancer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 166. Asia Pacific: Colorectal Cancer Drugs Sales Forecast by Region (2021-2026) (MT)
Table 167. Asia Pacific: Colorectal Cancer Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 168. Latin America: Colorectal Cancer Drugs Sales Forecast by Country (2021-2026) (MT)
Table 169. Latin America: Colorectal Cancer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 170. Middle East and Africa: Colorectal Cancer Drugs Sales Forecast by Country (2021-2026) (MT)
Table 171. Middle East and Africa: Colorectal Cancer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 172. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 173. Key Challenges
Table 174. Market Risks
Table 175. Main Points Interviewed from Key Colorectal Cancer Drugs Players
Table 176. Colorectal Cancer Drugs Customers List
Table 177. Colorectal Cancer Drugs Distributors List
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Colorectal Cancer Drugs Product Picture
Figure 2. Global Colorectal Cancer Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Picture
Figure 4. Epidermal Growth Factor Receptor (EGFR) Inhibitors Product Picture
Figure 5. Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors Product Picture
Figure 6. BRAF or MEK Inhibitors Product Picture
Figure 7. Tyrosine Kinase (TKI) Inhibitors Product Picture
Figure 8. Immunomodulators Product Picture
Figure 9. Global Colorectal Cancer Drugs Sales Market Share by Application in 2020 & 2026
Figure 10. Radiotherapy
Figure 11. Chemotherapy
Figure 12. Colorectal Cancer Drugs Report Years Considered
Figure 13. Global Colorectal Cancer Drugs Market Size 2015-2026 (US$ Million)
Figure 14. Global Colorectal Cancer Drugs Sales 2015-2026 (MT)
Figure 15. Global Colorectal Cancer Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Colorectal Cancer Drugs Sales Market Share by Region (2015-2020)
Figure 17. Global Colorectal Cancer Drugs Sales Market Share by Region in 2019
Figure 18. Global Colorectal Cancer Drugs Revenue Market Share by Region (2015-2020)
Figure 19. Global Colorectal Cancer Drugs Revenue Market Share by Region in 2019
Figure 20. Global Colorectal Cancer Drugs Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Colorectal Cancer Drugs Revenue in 2019
Figure 22. Colorectal Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Colorectal Cancer Drugs Sales Market Share by Type (2015-2020)
Figure 24. Global Colorectal Cancer Drugs Sales Market Share by Type in 2019
Figure 25. Global Colorectal Cancer Drugs Revenue Market Share by Type (2015-2020)
Figure 26. Global Colorectal Cancer Drugs Revenue Market Share by Type in 2019
Figure 27. Global Colorectal Cancer Drugs Market Share by Price Range (2015-2020)
Figure 28. Global Colorectal Cancer Drugs Sales Market Share by Application (2015-2020)
Figure 29. Global Colorectal Cancer Drugs Sales Market Share by Application in 2019
Figure 30. Global Colorectal Cancer Drugs Revenue Market Share by Application (2015-2020)
Figure 31. Global Colorectal Cancer Drugs Revenue Market Share by Application in 2019
Figure 32. North America Colorectal Cancer Drugs Sales Growth Rate 2015-2020 (MT)
Figure 33. North America Colorectal Cancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Colorectal Cancer Drugs Sales Market Share by Country in 2019
Figure 35. North America Colorectal Cancer Drugs Revenue Market Share by Country in 2019
Figure 36. U.S. Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 37. U.S. Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 39. Canada Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Colorectal Cancer Drugs Market Share by Type in 2019
Figure 41. North America Colorectal Cancer Drugs Market Share by Application in 2019
Figure 42. Europe Colorectal Cancer Drugs Sales Growth Rate 2015-2020 (MT)
Figure 43. Europe Colorectal Cancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Colorectal Cancer Drugs Sales Market Share by Country in 2019
Figure 45. Europe Colorectal Cancer Drugs Revenue Market Share by Country in 2019
Figure 46. Germany Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 47. Germany Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 49. France Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 51. U.K. Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 53. Italy Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 55. Russia Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Colorectal Cancer Drugs Market Share by Type in 2019
Figure 57. Europe Colorectal Cancer Drugs Market Share by Application in 2019
Figure 58. Asia Pacific Colorectal Cancer Drugs Sales Growth Rate 2015-2020 (MT)
Figure 59. Asia Pacific Colorectal Cancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Colorectal Cancer Drugs Sales Market Share by Region in 2019
Figure 61. Asia Pacific Colorectal Cancer Drugs Revenue Market Share by Region in 2019
Figure 62. China Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 63. China Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 65. Japan Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 67. South Korea Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 69. India Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 71. Australia Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 73. Taiwan Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 75. Indonesia Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 77. Thailand Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 79. Malaysia Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 81. Philippines Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 83. Vietnam Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Colorectal Cancer Drugs Market Share by Type in 2019
Figure 85. Asia Pacific Colorectal Cancer Drugs Market Share by Application in 2019
Figure 86. Latin America Colorectal Cancer Drugs Sales Growth Rate 2015-2020 (MT)
Figure 87. Latin America Colorectal Cancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Colorectal Cancer Drugs Sales Market Share by Country in 2019
Figure 89. Latin America Colorectal Cancer Drugs Revenue Market Share by Country in 2019
Figure 90. Mexico Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 91. Mexico Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 93. Brazil Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 95. Argentina Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Colorectal Cancer Drugs Market Share by Type in 2019
Figure 97. Latin America Colorectal Cancer Drugs Market Share by Application in 2019
Figure 98. Middle East and Africa Colorectal Cancer Drugs Sales Growth Rate 2015-2020 (MT)
Figure 99. Middle East and Africa Colorectal Cancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Colorectal Cancer Drugs Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Colorectal Cancer Drugs Revenue Market Share by Country in 2019
Figure 102. Turkey Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 103. Turkey Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 105. Saudi Arabia Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 107. U.A.E Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Colorectal Cancer Drugs Market Share by Type in 2019
Figure 109. Middle East and Africa Colorectal Cancer Drugs Market Share by Application in 2019
Figure 110. AB Science Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Array BioPharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Elli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Roch Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Hutchison MediPharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Merck & Co., Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Mologen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. Regeneron Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 123. Sumitomo Dainippon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 124. Taiho Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 125. Vaccinogen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 126. North America Colorectal Cancer Drugs Sales Growth Rate Forecast (2021-2026) (MT)
Figure 127. North America Colorectal Cancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Europe Colorectal Cancer Drugs Sales Growth Rate Forecast (2021-2026) (MT)
Figure 129. Europe Colorectal Cancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Asia Pacific Colorectal Cancer Drugs Sales Growth Rate Forecast (2021-2026) (MT)
Figure 131. Asia Pacific Colorectal Cancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 132. Latin America Colorectal Cancer Drugs Sales Growth Rate Forecast (2021-2026) (MT)
Figure 133. Latin America Colorectal Cancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 134. Middle East and Africa Colorectal Cancer Drugs Sales Growth Rate Forecast (2021-2026) (MT)
Figure 135. Middle East and Africa Colorectal Cancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 136. Porter's Five Forces Analysis
Figure 137. Channels of Distribution
Figure 138. Distributors Profiles
Figure 139. Bottom-up and Top-down Approaches for This Report
Figure 140. Data Triangulation
Figure 141. Key Executives Interviewed
Figure 1. Colorectal Cancer Drugs Product Picture
Figure 2. Global Colorectal Cancer Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Picture
Figure 4. Epidermal Growth Factor Receptor (EGFR) Inhibitors Product Picture
Figure 5. Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors Product Picture
Figure 6. BRAF or MEK Inhibitors Product Picture
Figure 7. Tyrosine Kinase (TKI) Inhibitors Product Picture
Figure 8. Immunomodulators Product Picture
Figure 9. Global Colorectal Cancer Drugs Sales Market Share by Application in 2020 & 2026
Figure 10. Radiotherapy
Figure 11. Chemotherapy
Figure 12. Colorectal Cancer Drugs Report Years Considered
Figure 13. Global Colorectal Cancer Drugs Market Size 2015-2026 (US$ Million)
Figure 14. Global Colorectal Cancer Drugs Sales 2015-2026 (MT)
Figure 15. Global Colorectal Cancer Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Colorectal Cancer Drugs Sales Market Share by Region (2015-2020)
Figure 17. Global Colorectal Cancer Drugs Sales Market Share by Region in 2019
Figure 18. Global Colorectal Cancer Drugs Revenue Market Share by Region (2015-2020)
Figure 19. Global Colorectal Cancer Drugs Revenue Market Share by Region in 2019
Figure 20. Global Colorectal Cancer Drugs Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Colorectal Cancer Drugs Revenue in 2019
Figure 22. Colorectal Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Colorectal Cancer Drugs Sales Market Share by Type (2015-2020)
Figure 24. Global Colorectal Cancer Drugs Sales Market Share by Type in 2019
Figure 25. Global Colorectal Cancer Drugs Revenue Market Share by Type (2015-2020)
Figure 26. Global Colorectal Cancer Drugs Revenue Market Share by Type in 2019
Figure 27. Global Colorectal Cancer Drugs Market Share by Price Range (2015-2020)
Figure 28. Global Colorectal Cancer Drugs Sales Market Share by Application (2015-2020)
Figure 29. Global Colorectal Cancer Drugs Sales Market Share by Application in 2019
Figure 30. Global Colorectal Cancer Drugs Revenue Market Share by Application (2015-2020)
Figure 31. Global Colorectal Cancer Drugs Revenue Market Share by Application in 2019
Figure 32. North America Colorectal Cancer Drugs Sales Growth Rate 2015-2020 (MT)
Figure 33. North America Colorectal Cancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Colorectal Cancer Drugs Sales Market Share by Country in 2019
Figure 35. North America Colorectal Cancer Drugs Revenue Market Share by Country in 2019
Figure 36. U.S. Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 37. U.S. Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 39. Canada Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Colorectal Cancer Drugs Market Share by Type in 2019
Figure 41. North America Colorectal Cancer Drugs Market Share by Application in 2019
Figure 42. Europe Colorectal Cancer Drugs Sales Growth Rate 2015-2020 (MT)
Figure 43. Europe Colorectal Cancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Colorectal Cancer Drugs Sales Market Share by Country in 2019
Figure 45. Europe Colorectal Cancer Drugs Revenue Market Share by Country in 2019
Figure 46. Germany Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 47. Germany Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 49. France Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 51. U.K. Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 53. Italy Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 55. Russia Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Colorectal Cancer Drugs Market Share by Type in 2019
Figure 57. Europe Colorectal Cancer Drugs Market Share by Application in 2019
Figure 58. Asia Pacific Colorectal Cancer Drugs Sales Growth Rate 2015-2020 (MT)
Figure 59. Asia Pacific Colorectal Cancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Colorectal Cancer Drugs Sales Market Share by Region in 2019
Figure 61. Asia Pacific Colorectal Cancer Drugs Revenue Market Share by Region in 2019
Figure 62. China Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 63. China Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 65. Japan Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 67. South Korea Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 69. India Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 71. Australia Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 73. Taiwan Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 75. Indonesia Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 77. Thailand Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 79. Malaysia Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 81. Philippines Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 83. Vietnam Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Colorectal Cancer Drugs Market Share by Type in 2019
Figure 85. Asia Pacific Colorectal Cancer Drugs Market Share by Application in 2019
Figure 86. Latin America Colorectal Cancer Drugs Sales Growth Rate 2015-2020 (MT)
Figure 87. Latin America Colorectal Cancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Colorectal Cancer Drugs Sales Market Share by Country in 2019
Figure 89. Latin America Colorectal Cancer Drugs Revenue Market Share by Country in 2019
Figure 90. Mexico Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 91. Mexico Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 93. Brazil Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 95. Argentina Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Colorectal Cancer Drugs Market Share by Type in 2019
Figure 97. Latin America Colorectal Cancer Drugs Market Share by Application in 2019
Figure 98. Middle East and Africa Colorectal Cancer Drugs Sales Growth Rate 2015-2020 (MT)
Figure 99. Middle East and Africa Colorectal Cancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Colorectal Cancer Drugs Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Colorectal Cancer Drugs Revenue Market Share by Country in 2019
Figure 102. Turkey Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 103. Turkey Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 105. Saudi Arabia Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Colorectal Cancer Drugs Sales Growth Rate (2015-2020) (MT)
Figure 107. U.A.E Colorectal Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Colorectal Cancer Drugs Market Share by Type in 2019
Figure 109. Middle East and Africa Colorectal Cancer Drugs Market Share by Application in 2019
Figure 110. AB Science Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Array BioPharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Elli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Roch Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Hutchison MediPharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Merck & Co., Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Mologen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. Regeneron Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 123. Sumitomo Dainippon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 124. Taiho Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 125. Vaccinogen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 126. North America Colorectal Cancer Drugs Sales Growth Rate Forecast (2021-2026) (MT)
Figure 127. North America Colorectal Cancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Europe Colorectal Cancer Drugs Sales Growth Rate Forecast (2021-2026) (MT)
Figure 129. Europe Colorectal Cancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Asia Pacific Colorectal Cancer Drugs Sales Growth Rate Forecast (2021-2026) (MT)
Figure 131. Asia Pacific Colorectal Cancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 132. Latin America Colorectal Cancer Drugs Sales Growth Rate Forecast (2021-2026) (MT)
Figure 133. Latin America Colorectal Cancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 134. Middle East and Africa Colorectal Cancer Drugs Sales Growth Rate Forecast (2021-2026) (MT)
Figure 135. Middle East and Africa Colorectal Cancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 136. Porter's Five Forces Analysis
Figure 137. Channels of Distribution
Figure 138. Distributors Profiles
Figure 139. Bottom-up and Top-down Approaches for This Report
Figure 140. Data Triangulation
Figure 141. Key Executives Interviewed
